Abstract:Introduction: Four epidemiological studies have shown a negative association between prenatal acrylamide exposure and birth size. In order to shed light on the possible underlying mechanism(s), we analysed associations between acrylamide biomarkers and biomarkers related to fetal growth. Methods: In newborns of the ENVIRONAGE birth cohort (n ranges from 215 to 434), we investigated the association between prenatal acrylamide exposure (acrylamide and glycidamide hemoglobin adduct levels in cord blood) and thyroid hormones (TSH, T3, T4 and the ratio of T4 to T3 in cord plasma), insulin-related factors (cord plasma insulin and IGF1, and placental IGF2), neurotrophins (cord plasma BDNF, and placental NGF, NT3 and NT4), and cord plasma homocysteine and progesterone, using multiple linear regression analysis. In addition, we investigated whether the biomarkers mediated the associations between prenatal acrylamide exposure and birth outcomes. Results: We observed lower cord plasma TSH (-10.2% [95% CI: -15.0, -4.3]) and higher placental NGF levels (10.0% [95% CI 3.7, 17.4]) for a twofold increase of acrylamide adducts, a decrease in the ratio of cord plasma free T4 and free T3 with higher acrylamide and glycidamide adducts of -2.9% (95% CI: -5.7, -0.1) and -3.9% (95% CI: -6.2, -1.6) for a twofold increase in acrylamide and glycidamide adduct levels, respectively, and higher cord plasma free T3 with increases in both acrylamide and glycidamide adducts of 2.8% (95% CI: 0.2, 5.6) and 3.6% (95% CI: 0.8, 6.6) for a twofold increase in acrylamide and glycidamide adduct levels, respectively. Additionally, a twofold increase in glycidamide adducts was associated with lower cord plasma insulin levels, particularly among newborns of non-smoking mothers (-11.2% [95% CI: -19.5, -0.1]). Cord plasma insulin seemed to mediate the association between glycidamide adducts and birth weight. Conclusions: A decrease in cord plasma insulin levels may be (a marker of) a mechanism by which gestational acrylamide exposure is associated with decreased fetal growth. The possible health consequences of the associations between gestational acrylamide exposure and thyroid hormones and neurotrophins warrant future study.

Gestational exposure to acrylamide inhibits mouse placental development in vivo.

Gestational exposure to acrylamide suppresses luteal endocrine function through dysregulation of ovarian angiogenesis, oxidative stress and apoptosis in mice

Exposure to Acrylamide Inhibits Uterine Decidualization Via Suppression of Cyclin D3/p21 and Apoptosis in Mice.

Ambient Fine Particulate Matter Exposure Disrupts Placental Autophagy and Fetal Development in Gestational Mice.

Acrylamide toxic effects on mouse oocyte quality and fertility in vivo

Exposure to Acrylamide Induces Zygotic Genome Activation Defects of Mouse Embryos

Reproductive Toxicity in Acrylamide-Treated Female Mice

Exposure to Ethephon Compromises Endometrial Decidualization in Mice During Early Pregnancy Via GPR120

Exposure to acrylamide induces skeletal developmental toxicity in zebrafish and rat embryos

Acrylamide Exposure Impairs Ovarian Tricarboxylic Acid Cycle and Reduces Oocyte Quality in Mouse

Effects of acrylamide exposure during pregnancy and lactation on the development of myelin sheath of corpus callosum in offspring rats

Maternal Exposure to Tributyltin During Early Gestation Increases Adverse Pregnancy Outcomes by Impairing Placental Development

Acrylamide Exposure Destroys the Distribution and Functions of Organelles in Mouse Oocytes

Gestational Perfluorooctanoic Acid Exposure Inhibits Placental Development by Dysregulation of Labyrinth Vessels and Unk Cells and Apoptosis in Mice.

Gestational diabetes mellitus impairs AKT-mTOR and SIRT1 signaling pathways in placenta

Acrylamide modulates the mouse epididymal proteome to drive alterations in the sperm small non-coding RNA profile and dysregulate embryo development

Gestational acrylamide exposure and biomarkers of fetal growth: Probing the mechanism underlying the association between acrylamide and reduced fetal growth

[Effect of Di-(2-ethylhexyl) Phthalate Exposure on Placental Development in Pregnant Mice].

Maternal exposure to a glyphosate-based herbicide impairs placental development through endoplasmic reticulum stress in mice

Fetal programming: in utero exposure to acrylamide leads to intergenerational disrupted ovarian function and accelerated ovarian aging

Research progress in biomarker analysis and risk assessment of acrylamide exposure in vivo